Alaunos
TCRT

股本结构

单位：万股
公告日期 2025-11-14 2025-10-22 2025-11-14 2025-08-21 2025-08-14 2025-08-14
证券总股本 223.18 232.18 220.58 220.57 219.49 207.47
普通股本 223.18 232.18 220.58 220.57 219.49 207.47
优先股 未披露 0.14 0.14 0.14 未披露 0.14
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-11-14 2025-10-20 2025-09-30 2025-08-20 2025-08-14 2025-06-30
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2025-11-14 223.18 未披露 定期报告 2025-11-14
2025-10-22 232.18 0.14 定期报告 2025-10-20
2025-11-14 220.58 0.14
更多>>
From June 30, 2025 to September 30, 2025 Shares issued as consideration for board service fees Shares issued as consideration for services Exercise of prefunded warrants
2025-09-30
2025-08-21 220.57 0.14 定期报告 2025-08-20
2025-08-14 219.49 未披露 定期报告 2025-08-14
2025-08-14 207.47 0.14
更多>>
From March 31, 2025 to June 30, 2025 Shares issued as consideration for board service fees Sale of Series A-1 preferred stock Issuance of common stock in registered direct offering, net of offering cost Exercise of prefunded warrants Sale of Series A-2 preferred stock
2025-06-30
2025-05-21 163.95 未披露 定期报告 2025-05-05
2025-04-30 163.95 未披露 定期报告 2025-04-30
2024-07-16 160.13 未披露
更多>>
a reverse stock split of the Company’s common stock at a ratio of 1-for-10
2024-07-18
2024-05-15 1601.25 未披露 定期报告 2024-03-31
2024-04-01 1601.25 未披露 定期报告 2024-03-27
2024-01-29 1604.18 未披露
更多>>
Alaunos Therapeutics, Inc. reversed stock split of the Company’s common stock at a ratio of 1-for-15,the Reverse Split effective on January 31, 2024 at 5:00 p.m. Eastern Time, Beginning with the opening of trading on Thursday, February 1, 2024, the Company’s common stock will continue to trade on The Nasdaq Capital Market.
2024-02-01
2023-03-07 24062.71 未披露 定期报告 2023-03-02
2022-11-30 24041.08 未披露
更多>>
Common stock offered 24,228,719 shares by the company
2022-12-01
2022-09-07 21618.20 未披露 定期报告 2022-09-02
2022-08-31 21620.08 未披露 定期报告 2022-08-29
2022-08-12 21617.45 未披露 定期报告 2022-08-10
2022-08-15 21617.45 未披露
更多>>
From March 31, 2022 to June 30, 2022 Cancelled restricted common stock Restricted stock awards
2022-06-30
2022-05-16 21595.06 未披露
更多>>
From December 31, 2021 to March 31, 2022 Cancelled restricted common stock
2022-03-31
2022-03-30 21612.74 未披露
更多>>
From December 31, 2020 to December 31, 2021 Exercise of employee stock options Common stock issuance Restricted stock awards Restricted stock awards
2021-12-31
2021-11-08 21614.58 未披露 定期报告 2021-10-29
2021-11-08 21614.58 未披露
更多>>
From June 30, 2021 to September 30, 2021 Restricted stock awards Cancelled restricted common stock
2021-09-30
2021-08-13 21555.91 未披露
更多>>
From March 31, 2021 to June 30, 2021 Exercise of employee stock options Restricted stock awards Cancelled restricted common stock
2021-06-30
2021-05-06 21552.54 未披露 定期报告 2021-04-30
2021-05-06 21525.77 未披露
更多>>
from December 31, 2020 to March 31, 2021 Exercise of employee stock options Restricted stock awards
2021-03-31
2021-04-07 21520.52 未披露 定期报告 2021-03-22
2021-04-07 21518.02 未披露 定期报告 2021-03-12
2021-03-01 21466.70 未披露 定期报告 2021-02-24
2021-03-01 21459.19 未披露
更多>>
from December 31, 2019 to December 31, 2020 Exercise of employee stock options Restricted stock awards Cancelled restricted common stock Issuance of common stock in connection with a public offering, net of commissions and expenses of $5,900 Issuance of common stock in connection with an at the market offering, net of commissions and expenses of $400
2020-12-31
2020-11-02 21429.11 未披露 定期报告 2020-10-29
2020-11-05 21416.57 未披露
更多>>
From June 30, 2020 to September 30, 2020 Exercise of employee stock options
2020-09-30
2020-08-06 21415.09 未披露 定期报告 2020-07-31
2020-08-06 21429.22 未披露
更多>>
From March 31, 2020 to June 30, 2020 Exercise of employee stock options
2020-06-30
2020-05-07 21428.63 未披露
更多>>
From December 31, 2019 to March 31, 2020 Exercise of employee stock options Issuance of restricted common stock Issuance of common stock in connection with a public offering, net of commissions and expenses of $5.9 million Issuance of common stock in connection with an at the market offering, net of commissions and expenses of $0.4 million
2020-03-31
2020-03-02 21300.00 未披露 定期报告 2020-02-14
2020-02-07 20885.61 未披露 定期报告 2020-02-07
2020-03-02 18180.33 未披露
更多>>
from December 31, 2018 to December 31, 2019 Issuance of restricted common stock Exercise of employee stock options Cancelled restricted common stock Repurchase of restricted common stock Issuance of common stock in connection with at the market offering, net of commssions and expenses of $0.1 million Warrant exercise, net of commissions and expenses of $1.1 million
2019-12-31
2019-11-07 18103.00 未披露
更多>>
From June 30, 2019 to September 30, 2019 Exercise of employee stock options Restricted stock awards Issuance of common stock upon exercise of warrants, net Issuance of common stock in connection with at the market offering, net
2019-09-30
2019-08-08 16255.30 未披露 定期报告 2019-07-24
2019-08-08 16247.80 未披露
更多>>
from March 31, 2019 to June 30,2019 Exercise of employee stock options Cancelled restricted common stock
2019-06-30
2019-06-21 16131.91 未披露 定期报告 2019-06-18
2019-05-08 16239.45 未披露 定期报告 2019-04-30
2019-05-08 16228.72 未披露
更多>>
From December 31,2018 to March 31, 2019 Issuance of restricted common stock Cancelled restricted common stock Repurchase of restricted common stock
2019-03-31
2019-03-05 16229.45 未披露 定期报告 2019-02-21
2019-03-05 16106.61 未披露
更多>>
From December 31,2017 to December 31,2018 Preferred stock dividends Settlement of a related party relationship Issuance of restricted common stock Exercise of employee stock options Cancelled restricted common stock Repurchase of restricted common stock Issuance of warrants and common stock in a private placement, net of commissions and expenses of $2,898
2018-12-31
2018-11-09 14237.98 13.08
更多>>
from December 31, 2017 to September 30, 2018 Preferred stock dividends Exercise of employee stock options Cancelled restricted common stock Repurchase of restricted common stock
2018-09-30
2018-08-08 14237.98 12.70
更多>>
from December 31, 2017 to June 30, 2018 Preferred stock dividends Exercise of employee stock options Cancelled restricted common stock Repurchase of restricted common stock
2018-06-30
2018-05-10 14239.89 未披露 定期报告 2018-04-24
2018-04-30 14265.16 未披露 定期报告 2018-04-17
2018-05-10 14239.89 12.33
更多>>
from December 31, 2017 to March 31, 2018 Preferred stock dividends Cancelled restricted common stock Repurchase of restricted common stock
2018-03-31
2018-03-01 14239.89 未披露 定期报告 2018-02-21
2018-03-01 14265.80 11.96
更多>>
from December 31, 2016 to December 31, 2017 Exercise of stock options Issuance of restricted common stock Repurchase of common stock Issuance of common stock, net of commissions and expenses of $2.7 million Preferred stock dividends
2017-12-31
2017-11-06 14196.28 11.61
更多>>
From December 31, 2016 To September 30, 2017 Preferred stock dividends Exercise of employee stock options Restricted stock buy-back at vesting to cover taxes Issuance of common stock, net of commissions and expenses of $2.7 million
2017-09-30
2017-07-31 14196.28 11.27
更多>>
from December 31, 2016 to June 30, 2017 Preferred stock dividends Exercise of employee stock options Restricted stock buy-back at vesting to cover taxes Issuance of common stock net of commissions and expenses of $2.7 million
2017-06-30
2017-04-28 13238.77 未披露 定期报告 2017-04-18
2017-05-01 13238.17 10.94
更多>>
from December 31, 2016 to March 31, 2017 Preferred stock dividends Exercise of employee stock options
2017-03-31
2017-02-16 13237.67 10.62
更多>>
from December 31, 2015 to December 31, 2016 Issuance of Series 1 Preferred Stock in a license agreement with Intrexon, net of issuance costs of $109 Preferred stock dividends Exercise of employee stock options Issuance of restricted common stock Repurchase of shares of common stock Stock buy-back
2016-12-31
2016-08-09 13173.24 未披露
更多>>
from December 31, 2015 to June 30, 2016 Exercise of employee stock options Repurchase of common stock Restricted stock buy-back at vesting to cover taxes
2016-06-30
2016-05-10 13184.04 未披露 定期报告 2016-04-26
2016-04-28 13180.89 未披露 定期报告 2016-04-19
2016-05-10 13180.29 未披露
更多>>
from December 31, 2015 to March 31, 2016 Exercise of employee stock options Repurchase of common stock
2016-03-31
2016-02-24 13171.86 未披露
更多>>
from December 31, 2014 to December 31, 2015 Exercise of employee stock options Issuance of restricted common stock Repurchase of shares of restricted common stock Repurchase of common stock Issuance of common stock, net of commissions and expenses of $6,305 Issuance of common stock in licensing agreement
2015-12-31
2015-08-10 13085.21 未披露 定期报告 2015-07-25
2015-08-10 13082.20 未披露
更多>>
from December 31, 2014 to June 30, 2015 Exercise of employee stock options Restricted stock awards Repurchase of common stock Repurchase of restricted common stock Issuance of common stock in public offering, net of $267 thousand in issuance expenses Issuance of common stock in licensing agreement
2015-06-30
2015-04-30 12826.88 未披露 定期报告 2015-04-22
2015-05-07 12823.25 未披露
更多>>
from December 31, 2014 to March 31, 2015 Exercise of employee stock options Repurchase of shares of restricted common stock Issuance of common stock in public offering, net of $267 thousand in issuance expenses Issuance of common stock in licensing agreement
2015-03-31
2014-10-30 10271.15 未披露 定期报告 2014-10-30
2014-08-07 10074.29 未披露 定期报告 2014-07-31
2014-05-08 10072.60 未披露 定期报告 2014-04-30
2014-04-30 10073.20 未披露 定期报告 2014-04-21
2014-03-03 10055.66 未披露 定期报告 2014-02-10
From June 30, 2025 to September 30, 2025 Shares issued as consideration for board service fees Shares issued as consideration for services Exercise of prefunded warrants
From March 31, 2025 to June 30, 2025 Shares issued as consideration for board service fees Sale of Series A-1 preferred stock Issuance of common stock in registered direct offering, net of offering cost Exercise of prefunded warrants Sale of Series A-2 preferred stock
a reverse stock split of the Company’s common stock at a ratio of 1-for-10
Alaunos Therapeutics, Inc. reversed stock split of the Company’s common stock at a ratio of 1-for-15,the Reverse Split effective on January 31, 2024 at 5:00 p.m. Eastern Time, Beginning with the opening of trading on Thursday, February 1, 2024, the Company’s common stock will continue to trade on The Nasdaq Capital Market.
Common stock offered 24,228,719 shares by the company
From March 31, 2022 to June 30, 2022 Cancelled restricted common stock Restricted stock awards
From December 31, 2021 to March 31, 2022 Cancelled restricted common stock
From December 31, 2020 to December 31, 2021 Exercise of employee stock options Common stock issuance Restricted stock awards Restricted stock awards
From June 30, 2021 to September 30, 2021 Restricted stock awards Cancelled restricted common stock
From March 31, 2021 to June 30, 2021 Exercise of employee stock options Restricted stock awards Cancelled restricted common stock
from December 31, 2020 to March 31, 2021 Exercise of employee stock options Restricted stock awards
from December 31, 2019 to December 31, 2020 Exercise of employee stock options Restricted stock awards Cancelled restricted common stock Issuance of common stock in connection with a public offering, net of commissions and expenses of $5,900 Issuance of common stock in connection with an at the market offering, net of commissions and expenses of $400
From June 30, 2020 to September 30, 2020 Exercise of employee stock options
From March 31, 2020 to June 30, 2020 Exercise of employee stock options
From December 31, 2019 to March 31, 2020 Exercise of employee stock options Issuance of restricted common stock Issuance of common stock in connection with a public offering, net of commissions and expenses of $5.9 million Issuance of common stock in connection with an at the market offering, net of commissions and expenses of $0.4 million
from December 31, 2018 to December 31, 2019 Issuance of restricted common stock Exercise of employee stock options Cancelled restricted common stock Repurchase of restricted common stock Issuance of common stock in connection with at the market offering, net of commssions and expenses of $0.1 million Warrant exercise, net of commissions and expenses of $1.1 million
From June 30, 2019 to September 30, 2019 Exercise of employee stock options Restricted stock awards Issuance of common stock upon exercise of warrants, net Issuance of common stock in connection with at the market offering, net
from March 31, 2019 to June 30,2019 Exercise of employee stock options Cancelled restricted common stock
From December 31,2018 to March 31, 2019 Issuance of restricted common stock Cancelled restricted common stock Repurchase of restricted common stock
From December 31,2017 to December 31,2018 Preferred stock dividends Settlement of a related party relationship Issuance of restricted common stock Exercise of employee stock options Cancelled restricted common stock Repurchase of restricted common stock Issuance of warrants and common stock in a private placement, net of commissions and expenses of $2,898
from December 31, 2017 to September 30, 2018 Preferred stock dividends Exercise of employee stock options Cancelled restricted common stock Repurchase of restricted common stock
from December 31, 2017 to June 30, 2018 Preferred stock dividends Exercise of employee stock options Cancelled restricted common stock Repurchase of restricted common stock
from December 31, 2017 to March 31, 2018 Preferred stock dividends Cancelled restricted common stock Repurchase of restricted common stock
from December 31, 2016 to December 31, 2017 Exercise of stock options Issuance of restricted common stock Repurchase of common stock Issuance of common stock, net of commissions and expenses of $2.7 million Preferred stock dividends
From December 31, 2016 To September 30, 2017 Preferred stock dividends Exercise of employee stock options Restricted stock buy-back at vesting to cover taxes Issuance of common stock, net of commissions and expenses of $2.7 million
from December 31, 2016 to June 30, 2017 Preferred stock dividends Exercise of employee stock options Restricted stock buy-back at vesting to cover taxes Issuance of common stock net of commissions and expenses of $2.7 million
from December 31, 2016 to March 31, 2017 Preferred stock dividends Exercise of employee stock options
from December 31, 2015 to December 31, 2016 Issuance of Series 1 Preferred Stock in a license agreement with Intrexon, net of issuance costs of $109 Preferred stock dividends Exercise of employee stock options Issuance of restricted common stock Repurchase of shares of common stock Stock buy-back
from December 31, 2015 to June 30, 2016 Exercise of employee stock options Repurchase of common stock Restricted stock buy-back at vesting to cover taxes
from December 31, 2015 to March 31, 2016 Exercise of employee stock options Repurchase of common stock
from December 31, 2014 to December 31, 2015 Exercise of employee stock options Issuance of restricted common stock Repurchase of shares of restricted common stock Repurchase of common stock Issuance of common stock, net of commissions and expenses of $6,305 Issuance of common stock in licensing agreement
from December 31, 2014 to June 30, 2015 Exercise of employee stock options Restricted stock awards Repurchase of common stock Repurchase of restricted common stock Issuance of common stock in public offering, net of $267 thousand in issuance expenses Issuance of common stock in licensing agreement
from December 31, 2014 to March 31, 2015 Exercise of employee stock options Repurchase of shares of restricted common stock Issuance of common stock in public offering, net of $267 thousand in issuance expenses Issuance of common stock in licensing agreement
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。